| Dr Joseph Thomas King Jr, MD | |
|
950 Campbell Ave, Surgery/112, West Haven, CT 06516-2770 | |
| (203) 932-5711 | |
| (203) 937-3845 |
| Full Name | Dr Joseph Thomas King Jr |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 950 Campbell Ave, West Haven, Connecticut |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013941533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD042864L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Thomas King Jr, MD 950 Campbell Ave, Surgery/112, West Haven, CT 06516-2770 Ph: (203) 932-5711 | Dr Joseph Thomas King Jr, MD 950 Campbell Ave, Surgery/112, West Haven, CT 06516-2770 Ph: (203) 932-5711 |
News Archive
Rutgers' RUCDR Infinite Biologics has launched a test for the SARS-CoV-2 coronavirus and is using its automation experience and infrastructure to test as many as tens of thousands of samples daily.
Phase Forward, a leading provider of data solutions for clinical trials and drug safety, today announced the availability of version 7.2 of its Empirica™ Signal product, a significant new release of the company's flagship signal detection and management software. The Empirica Signal solution is a state-of-the-art data mining and knowledge management tool and a cornerstone component of Phase Forward's Empirica Suite of pharmacovigilance and risk management products.
Researchers from Spain established that liver stiffness, measured by transient elastography (TE), is an independent predictor of liver failure, hepatocellular carcinoma (HCC), and mortality in cirrhotic patients coinfected with the human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), and hepatitis C virus (HCV).
A common point in all human tumors is that they produce an activation of oncogenes, genes that cause cancer and they also cause a loss of function of the protective genes, called anti-oncogenes or tumour suppressor genes. Normally both categories of anticancer and procancer genes are in different regions of our chromosomes.
› Verified 6 days ago